229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-21.52%
Negative revenue growth while VUZI stands at 20.16%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-21.54%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-27.74%
Negative EBIT growth while VUZI is at 3.95%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-27.74%
Negative operating income growth while VUZI is at 3.95%. Joel Greenblatt would press for urgent turnaround measures.
-27.78%
Negative net income growth while VUZI stands at 5.46%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-27.01%
Negative EPS growth while VUZI is at 5.88%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-27.62%
Negative diluted EPS growth while VUZI is at 5.88%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.69%
Share reduction while VUZI is at 0.07%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.70%
Reduced diluted shares while VUZI is at 0.07%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-3.00%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-40.03%
Negative OCF growth while VUZI is at 28.80%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-41.92%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
298.63%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
136.15%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
92.58%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
223.59%
10Y OCF/share CAGR above 1.5x VUZI's 84.23%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
187.73%
5Y OCF/share CAGR above 1.5x VUZI's 60.44%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
189.99%
3Y OCF/share CAGR above 1.5x VUZI's 65.84%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
245.56%
Positive 10Y CAGR while VUZI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
191.18%
5Y net income/share CAGR above 1.5x VUZI's 21.01%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
148.46%
3Y net income/share CAGR above 1.5x VUZI's 14.16%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
5.59%
Below 50% of VUZI's 296.00%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-35.45%
Negative 5Y equity/share growth while VUZI is at 254.04%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-26.88%
Negative 3Y equity/share growth while VUZI is at 187.82%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
53.67%
Dividend/share CAGR of 53.67% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
19.92%
3Y dividend/share CAGR of 19.92% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-30.42%
Firm’s AR is declining while VUZI shows 7.81%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.08%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-8.01%
Negative asset growth while VUZI invests at 3.95%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-5.65%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-2.29%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.28%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-3.97%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
